Photo Gallery



News & Updation

  • OCTOBER 2018 Issue has been successfully launched on 1 October 2018

  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from 6.647 to 7.421 due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.



Swathi S.*, Subhashini Vedagiri Radhakrishnan* and Santhosh Kumar V.


COPD is one of most common chronic disease affecting 0.5-1% of world’s population that predominately in women. Emotional stress, air pollution, passive smoking and food habits play an important role in COPD. This present study is to ascertain rationality with of fixed dose combination-Deriphylline (theophylline and etophylline) SR in COPD patients after classifying according to GOLD guidelines in urban population. Patients were included in this study after receiving the patient consent form according to the ethical committee. Measurements such as Borg dyspnoea scale, St. George’s respiratory questionnaire, Medical research council (MRC) breathlessness scale. Clinical evidence supports the effectiveness of multiple drug therapies, however in the absence of long term data. The purpose of this research is to provide an overview of different clinical approaches and highlight some of the important issues surrounding the choice of drugs to be used in COPD. The purpose of this research is to provide comprehensive disease management strategy, which included a patient education session, a self-treatment plan for exacerbations and a monthly follow-up, is associated with a lower hospitalization rate. This study is also designed to alleviate symptoms; to prevent exacerbations; to preserve optimal lung function; to improve activities of daily living, quality of life and survival; with minimal adverse effects from treatment.

Keywords: COPD, Deriphylline, GOLD Guidelines.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More